WVE Initiates Phase 2a Trial
Wave Life Sciences initiates Phase 2a portion of INLIGHT trial of WVE-007 for obesity and cardiometabolic diseases
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.